Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 594

How can you not be bullish the US?

Great question. (Wish I had asked it 5, 10 or 15 years ago.) Near-term – say, to pick a random date, until 20 January 2025 – momentum may stay with the US trade. But beyond that US equities look rich, their EPS advantage may narrow, rising bond yields may crimp returns, and the next cycle – which isn’t here yet – should favour other markets. I’m not convinced Trump can offset these headwinds.

Who’s not bullish the US? Exhibit 1 – nicked from Torsten Slok – shows the share of US consumers expecting higher equity prices is now at an all-time high. The AAII survey is also high (not at a record). So is Mike Hartnett’s BoA fund manager survey. I don’t know when this will peak. The bulls can project their hopes and dreams on the President-elect until inauguration day (20 January 2025).

Exhibit 1: Everyone (almost) expects higher equity prices

Source: Conference Board, NBER; Minack Advisors (thanks Torsten Slok)

The key to US exceptionalism has been earnings out-performance. Since 2016 EPS-driven out-performance has been enhanced by the US market rerating versus other markets (Exhibit 2).

Exhibit 2: Earnings drove most (not all) US exceptionalism

Source: MSCI, IBES/DataStream, NBER; Minack Advisors

That rerating coincided with a widening gap between US and non-US long-run EPS forecasts. The gap between expected US and non-US long-run EPS growth is now at 8%, a record, excluding 4 months in the GFC (Exhibit 3).

Exhibit 3: US exceptionalism is for the long run

Source: MSCI, IBES/DataStream, NBER; Minack Advisors

I doubt that US EPS growth will outpace the rest of the world’s by that much. Even if it does, that superior EPS growth is now in the price. Exhibit 4 shows prospective PE ratios based on long-run (5 years ahead) EPS level. The US market has re-rated relative to other developed markets even after taking into account its faster long-run EPS growth.

Exhibit 4: US is expensive even with exceptional EPS

Source: MSCI, IBES/DataStream, NBER; Minack Advisors

The US market is expensive relative to its own history, relative to other markets and relative to other assets. The prospective earnings yield is now in line with the 10-year Treasury yield (Exhibit 5). I expect 10-year yields to breach 5% in 2025. At some stage rising long-end yields will be a headwind for equity valuations in the US.

Exhibit 5: Exceptional valuation at risk from bond yields

Source: MSCI, IBES/DataStream, Bloomberg, NBER; Minack Advisors

The post-GFC cycle saw unusually strong US EPS growth and unusually weak EPS growth outside the US. Why will that change? The principal reason why ex-US EPS has been so weak since the GFC is that earnings had ballooned to unsustainable levels before the GFC. EPS in US$ terms quadrupled between 2002 and 2008. That EPS bubble bursting kept EPS weak for several years. However, rest of world EPS is now back on its pre-bubble trend and has resumed normal growth through the past few years (Exhibit 6).

Exhibit 6: The rest of the world back on EPS growth trend

Source: MSCI, NBER; Minack Advisors

US EPS has grown at an above-average pace since the GFC: 4% real over the past decade versus a long run average of 1.75%. Most of that exceptional growth – and most of the recent US EPS out-performance versus other markets – is due to the Magnificent 7 (Exhibit 7). I don’t analyse single names, so I don’t have a strong view on how long the Magnificent 7 can maintain EPS growth at recent rates. At some stage the law of large numbers will have to kick in. But several clients have commented that 2025 will be the ‘show me the money’ year where investors will want companies to show the payoff for the massive investment in artificial intelligence. If the returns aren’t there, valuations could fall.

Exhibit 7: Mag 7 explains most of US EPS exceptionalism

Source: Bloomberg, IBES/DataStream, MSCI, NBER; Minack Advisors

Much of the recent EPS out-performance of the S&P493 versus the rest of the world has been driven by diverging macro growth rates (Exhibit 8). However, I expect the growth gap between the US and the rest of the world to narrow in 2025.

Exhibit 8: This was not the year for RoW recovery

Source: Bloomberg, NBER; Minack Advisors

Mr Trump’s election has turbocharged US outperformance. While there may be a few sectors that benefit from specific policies, it’s not clear to me that Trump locks in sustained US equity outperformance. The cycle gap between the US and non-US markets should narrow next year. The prospect of higher long-end yields is a greater threat to the expensive US market. Mag 7 performance will be tested if AI underwhelms. And everyone is so bullish the US, who’s not already in?

 

Gerard Minack founded Minack Advisors in 2013 and has a wealth of experience as a macro strategist.

This article contains material based upon publicly available information, obtained from sources considered reliable, and is not soliciting any action based upon it. Opinions expressed are current as of the date of publication. All forecasts and statements about the future, even if presented as fact, should be treated as judgments, and neither Minack Advisors Pty Ltd nor its partners can be held responsible for any failure of those judgments to prove accurate. Minack Advisors Pty Ltd is regulated by ASIC, authorised representative number 443937.

 

  •   15 January 2025
  • 1
  •      
  •   

RELATED ARTICLES

Are the good times about to end?

UniSuper’s boss flags a potential correction ahead

2025: Another bullish year ahead for equities?

banner

Most viewed in recent weeks

Noel Whittaker’s take on the budget

Marketed as a fix for inequality and housing affordability, the latest budget instead delivers a tangle of tax changes that leave everyday Australians worse off.

Australia has no death duties. Technically.

Australia may not levy formal death duties, but a growing web of tax measures is quietly shaping what wealth passes between generations. Now, the 2026 budget adds another layer.

Lithium's rally is real this time – but no-one trusts it

The lithium rally mirrors the early-2010s tech stock surge, with demand set to double by 2030. Supply has been slow to respond, creating a market deficit for future tech like humanoid robotics and solid-state batteries.

Welcome to Firstlinks Edition 662 with weekend update

The debate over the budget is increasingly shaped by frustration and perceptions of unfairness, rather than clear-eyed assessment of policy outcomes.

How inflation is quietly moving the goalposts on retirement

Inflation doesn’t just raise today’s bills - it quietly increases the amount needed to retire, while simultaneously making it harder to save. Three steps to take before June 30th to improve retirement outcomes.

How to minimise tax with a will

Inheritance tax implications in Australia may surprise some, as poor estate planning without proper wills or trusts can lead to costly tax bills and delays for beneficiaries.

Latest Updates

SMSF strategies

Meg on SMSFs: The CGT changes don’t impact super but what about Div 296 tax decisions?

New CGT rules could tip the scales in the super vs non-super debate. For those facing the Division 296 tax, the case for withdrawing has gotten more complex. A "comparison rate" tool may help assess decisions.

Planning

Testamentary trusts post-budget: Estate planning, tax reform and the ‘death tax’ debate

Proposed Budget changes to taxation are casting new uncertainty over testamentary trusts, prompting closer scrutiny of estate planning structures and the real implications of reforms still taking shape.

Taxation

Income tax and bracket creep

Examining how five "tax cuts" stack up against bracket creep. Why offsets and incremental changes may do little to ease rising average tax burdens, compared to structural reform through indexation over time.  

Exchange traded products

The limits of a quality investing approach in Australia

Quality strategies shine globally, but Australia's concentrated market tells a different story. Limited diversification and sector dominance can constrain the defensive outcomes investors have seen in broader markets.

Investment strategies

Balancing opportunity and complexity

As private markets expand, investors face a growing mix of structures, a stabilising private equity cycle and uneven AI disruption. Fresh questions are being raised about where the real opportunities now sit.

Investment strategies

Why strong returns matter as much as generosity

As EOFY approaches, structured giving offers a tax-effective way to support charities, while allowing donations to grow over time and play a longer-term role in family wealth and legacy planning outcomes.

Investment strategies

The most important investment decision you’ll ever make

Stock picking often gets the spotlight, but research shows asset allocation explains the vast majority of long‑term returns. Understanding your mix of growth and defensive assets is the real key to investment success.

Sponsors

Alliances

© 2026 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.